HomeCompareHLVX vs HDV

HLVX vs HDV: Dividend Comparison 2026

HLVX yields 95.69% · HDV yields 2.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HLVX wins by $3.24M in total portfolio value
10 years
HLVX
HLVX
● Live price
95.69%
Share price
$2.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.26M
Annual income
$1,067,397.24
Full HLVX calculator →
HDV
iShares Core High Dividend ETF
● Live price
2.92%
Share price
$135.72
Annual div
$3.96
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.3K
Annual income
$351.71
Full HDV calculator →

Portfolio growth — HLVX vs HDV

📍 HLVX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHLVXHDV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HLVX + HDV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HLVX pays
HDV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HLVX
Annual income on $10K today (after 15% tax)
$8,133.97/yr
After 10yr DRIP, annual income (after tax)
$907,287.65/yr
HDV
Annual income on $10K today (after 15% tax)
$247.92/yr
After 10yr DRIP, annual income (after tax)
$298.95/yr
At 15% tax rate, HLVX beats the other by $906,988.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HLVX + HDV for your $10,000?

HLVX: 50%HDV: 50%
100% HDV50/50100% HLVX
Portfolio after 10yr
$1.64M
Annual income
$533,874.48/yr
Blended yield
32.49%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HLVX buys
0
HDV buys
0
No recent congressional trades found for HLVX or HDV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHLVXHDV
Forward yield95.69%2.92%
Annual dividend / share$2.00$3.96
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$3.26M$24.3K
Annual income after 10y$1,067,397.24$351.71
Total dividends collected$2.90M$3.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: HLVX vs HDV ($10,000, DRIP)

YearHLVX PortfolioHLVX Income/yrHDV PortfolioHDV Income/yrGap
1← crossover$20,269$9,569.38$11,002$291.67+$9.3KHLVX
2$39,816$18,127.60$12,082$299.61+$27.7KHLVX
3$75,882$33,279.13$13,247$307.23+$62.6KHLVX
4$140,469$59,275.00$14,503$314.52+$126.0KHLVX
5$252,850$102,548.32$15,854$321.50+$237.0KHLVX
6$443,065$172,515.34$17,308$328.15+$425.8KHLVX
7$756,599$282,519.41$18,871$334.49+$737.7KHLVX
8$1,260,443$450,881.99$20,551$340.53+$1.24MHLVX
9$2,050,673$701,999.14$22,357$346.27+$2.03MHLVX
10$3,261,617$1,067,397.24$24,296$351.71+$3.24MHLVX

HLVX vs HDV: Complete Analysis 2026

HLVXStock

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

Full HLVX Calculator →

HDVETF

The iShares Core High Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full HDV Calculator →
📬

Get this HLVX vs HDV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HLVX vs SCHDHLVX vs JEPIHLVX vs OHLVX vs KOHLVX vs MAINHLVX vs VYMHLVX vs DVYHLVX vs SPHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.